Physician profile
Mackenzie Waldran
NPI 1689358780
$586.58
in general payments reported to CMS, 2019-2025
15 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $369 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562 · Grant: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.58 |
| Grant | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $104.94 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Silk Road Medical, INC. | $58.65 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Mimedx Group, INC. | $57.77 | 2024 | |
| Boston Scientific Corporation | $50.46 | 2025 | Enroute Transcarotid Neuroprotection System |
| Ossur Americas, INC. | $43.78 | 2025 | |
| Bard Peripheral Vascular, INC. | $41.48 | 2024 | Pristine |
| Janssen Pharmaceuticals, INC | $33.85 | 2024 | Xarelto |
| Integra Lifesciences Corporation | $32.64 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Cagent Vascular INC | $28.93 | 2025 | Serrantor |
| Mozarc Medical US LLC | $28.67 | 2025 | Palindrome |
| Inspiremd LTD | $25.61 | 2025 | Cguard Prime Carotid Stent System |
| Shockwave Medical, INC | $25.00 | 2025 | |
| Terumo Medical Corporation | $24.49 | 2024 | Azur Cx Detachable, Angio-Seal |
| Lemaitre Vascular, INC. | $15.20 | 2024 | Artegraft Vascular Graft |
| Tactile Systems Technology INC | $15.11 | 2025 | Flexitouch Plus, Nimbl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Waldran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.